State of Wisconsin Investment Board
LXRX icon

State of Wisconsin Investment Board’s Lexicon Pharmaceuticals LXRX Stock Holding History

State of Wisconsin Investment Board’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-15,034
Closed -$11.1K – 2298
2024
Q4 		$11.1K Buy
15,034
+2,602
+21% +$3.14K ﹤0.01% 2254
2024
Q3 		$19.5K Buy
+12,432
New +$22.1K ﹤0.01% 2264
2023
Q4 		– Sell
-62,077
Closed -$67.7K – 2480
2023
Q3 		$67.7K Buy
62,077
+553
+0.9% +$970 ﹤0.01% 2396
2023
Q2 		$141K Sell
61,524
-2,241
-4% -$5.95K ﹤0.01% 2195
2023
Q1 		$155K Sell
63,765
-7,078
-10% -$16.2K ﹤0.01% 2319
2022
Q4 		$135K Sell
70,843
-4,244
-6% -$9.03K ﹤0.01% 2307
2022
Q3 		$180K Buy
75,087
+60,519
+415% +$168K ﹤0.01% 2426
2022
Q2 		$27K Sell
14,568
-73,232
-83% -$140K ﹤0.01% 2728
2022
Q1 		$183K Sell
87,800
-69,700
-44% -$193K ﹤0.01% 2191
2021
Q4 		$621K Sell
157,500
-1,700
-1% -$8.26K ﹤0.01% 1613
2021
Q3 		$766K Buy
159,200
+5,500
+4% +$22.6K ﹤0.01% 1533
2021
Q2 		$705K Buy
153,700
+99,100
+182% +$477K ﹤0.01% 1577
2021
Q1 		$321K Buy
+54,600
New +$378K ﹤0.01% 1824
2020
Q3 		– Sell
-64,000
Closed -$128K – 1970
2020
Q2 		$128K Hold
64,000
– – ﹤0.01% 1622
2020
Q1 		$125K Buy
64,000
+4,800
+8% +$14.3K ﹤0.01% 1594
2019
Q4 		$246K Hold
59,200
– – ﹤0.01% 1569
2019
Q3 		$178K Hold
59,200
– – ﹤0.01% 1509
2019
Q2 		$372K Buy
59,200
+1,300
+2% +$7.78K ﹤0.01% 1396
2019
Q1 		$322K Buy
57,900
+13,300
+30% +$80.8K ﹤0.01% 1415
2018
Q4 		$296K Buy
44,600
+13,600
+44% +$110K ﹤0.01% 1414
2018
Q3 		$331K Sell
31,000
-92,156
-75% -$1.06M ﹤0.01% 1457
2018
Q2 		$1.48M Sell
123,156
-46,300
-27% -$474K ﹤0.01% 1054
2018
Q1 		$1.45M Buy
169,456
+138,456
+447% +$1.28M ﹤0.01% 1027
2017
Q4 		$306K Hold
31,000
– – ﹤0.01% 1359
2017
Q3 		$381K Hold
31,000
– – ﹤0.01% 1347
2017
Q2 		$510K Buy
+31,000
New +$480K ﹤0.01% 1273

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State of Wisconsin Investment Board's LXRX Position: Q1 2025 in Review

State of Wisconsin Investment Board sold out of Lexicon Pharmaceuticals (LXRX) in Q1 2025, closing a stake of 15,034 shares — an estimated $11.1K sold.

State of Wisconsin Investment Board first reported a position in LXRX in Q2 2017 and held it in 26 quarters. The position peaked at $1.48M in Q2 2018. 127 funds tracked by Wall St. Rank hold LXRX as of Q1 2025.

  • State of Wisconsin Investment Board reported no remaining Lexicon Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 15,034 Lexicon Pharmaceuticals shares in Q1 2025, an estimated $11.1K.
  • State of Wisconsin Investment Board first reported a position in Lexicon Pharmaceuticals in Q2 2017 and held it in 26 quarters.
  • State of Wisconsin Investment Board's Lexicon Pharmaceuticals position peaked at $1.48M in Q2 2018.
  • 127 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2025.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2025, filed 15 May 2025.